ArticleBMC pulmonary medicine2026
Clinical and phenotypic characteristics of chronic cough patients without sputum eosinophilia.
Article in BMC pulmonary medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
Abstract
backgroundCorticosteroid treatment has no effect in patients without sputum eosinophilia. Sputum neutrophils and lymphocytes contribute to chronic cough hypersensitivity. The characteristics of chronic cough patients without sputum eosinophilia have not been investigated.
methodsThis study included a total of 1061 patients at the First Affiliated Hospital of Guangzhou Medical University between July 2021 and June 2024 (Approval number: ES-2024-K117-02). We analyzed clinical characteristics, sputum cell profiles, spirometry, and pulmonary lesions across four groups: chronic cough patients with normal sputum (n = 180), lymphocytotic sputum (n = 270), neutrophilic sputum (n = 349), and mixed leukocytotic sputum (n = 262).
resultsGastroesophageal reflux cough was the most prevalent disease in chronic cough patients with normal sputum. Atopic cough was more common in patients with lymphocytotic sputum. COPD and bronchiectasis were more prevalent in both neutrophilic and leukocytotic sputum groups. Advanced age was a characteristic of patients with neutrophilic or leukocytotic sputum. Patients with neutrophilic sputum had a higher prevalence of smoking history and a longer smoking duration. Pulmonary lesions were less severe in patients with lymphocytotic sputum but more severe in those with neutrophilic or leukocytotic sputum. Compared to patients with normal sputum, both neutrophilic and leukocytotic sputum groups exhibited marked reductions in overall lung function (FVC% of predicted, FEV1% of predicted, FEV1/FVC% of predicted, and PEF% of predicted) and small airway function (MMEF% of predicted, FEF75% of predicted, and FEF50% of predicted). Associations were observed among age, smoking history, sputum neutrophil percentages, pulmonary lesions, and declined lung functions. Elevated sputum neutrophils were independently associated with reduced lung function across multiple parameters (FVC% of predicted, FEV1/FVC% predicted, FEV1/VCmax% predicted, PEF% predicted, MMEF% of predicted, and FEF50% of predicted), despite robust adjustment for age and the presence of COPD, bronchiectasis, and interstitial lung disease.
conclusionsAdvanced age and smoking history are risk factors for elevated sputum neutrophils in chronic cough patients. Neutrophil-mediated airway inflammation is associated with pulmonary lesions and declined lung functions in chronic cough patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.